Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





FDA Cleared Blood Lead Testing System Displayed at AACC

By LabMedica International staff writers
Posted on 27 Jul 2015
US Food and Drug Administration (FDA) 510(k) clearance has been given for a new compact, relatively low cost analyzer to quantify lead levels in blood. More...


The “LeadCare Plus” clinical lead analyzer from Magellan Diagnostics (Billerica, MA, USA) offers simple-to-perform lead analysis with a compact footprint that makes blood lead testing accessible and practical for labs of any size. With dimensions smaller than a laptop, single-use consumables, and electronic calibration, the system is easy to implement even in space- and resource-constrained labs. The LeadCare Plus system is based on technology developed by Magellan Diagnostics that has been in clinical use for nearly two decades.

Blood lead testing is a critical preventative service: symptoms of lead exposure are nonspecific and subclinical, so a routine blood test is often the only way to identify exposure. According to the Centers for Disease Control and Prevention (CDC), there are over half a million children just in the USA still affected with elevated blood lead levels. Without early detection, elevated blood lead levels can impair cognition, reduce IQ, and cause attention-deficit disorders.

Amy Winslow, president, Magellan Diagnostics, said, "We are pleased that the FDA has cleared the LeadCare Plus System. Our mission is to help expand access to blood lead testing by offering a solution for every setting. With our other products CLIA-waived LeadCare II for point-of-care testing and LeadCare Ultra for high throughput lab analysis, LeadCare Plus completes this offering by providing a low capital cost system that gives even small labs the opportunity to bring this test in-house."

All three products will be on display during AACC 2015 (July 26–30; Atlanta, GA, USA) Clinical Lab Expo, Booth 3254.

Related Links:

Magellan Diagnostics
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The patented biosensor measures enzymatic activity associated with inflammatory disease (Photo courtesy of Hawkeye Bio)

Non-Invasive and Radiation-Free Diagnostic Identifies Early-Stage Lung Cancer Across All Subtypes

Lung cancer remains the leading cause of cancer-related deaths, with nearly 125,000 deaths and 227,000 new cases estimated in the U.S. for 2025. Despite evidence showing that early detection significantly... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.